AVITA Medical, Inc.

Informe acción NasdaqCM:RCEL

Capitalización de mercado: US$319.9m

Salud financiera de hoja de balance de AVITA Medical

Salud financiera controles de criterios 3/6

AVITA Medical tiene un patrimonio de los accionistas total de $12.2M y una deuda total de $42.5M, lo que sitúa su ratio deuda-patrimonio en 348%. Sus activos y pasivos totales son $81.1M y $68.8M respectivamente.

Información clave

348.0%

Ratio deuda-patrimonio

US$42.55m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$44.41m
PatrimonioUS$12.23m
Total pasivoUS$68.82m
Activos totalesUS$81.05m

Actualizaciones recientes sobre salud financiera

Recent updates

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Oct 04
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 11
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 18
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Jun 18
Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

Apr 12
Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

Feb 02
AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Oct 20
The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Avita Medical appoints James Corbett as CEO

Sep 29

AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal

Sep 12

Avita's burn therapy Recell gets insurance coverage in Japan following approval

Sep 01

AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M

Aug 11

AVITA Medical Is Interesting, But Not Just Yet

Dec 21

AVITA Medical reports preliminary Q2 revenue in-line with consensus

Jan 12

AVITA: COVID-19's Impact

Nov 17

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($63.9M) de RCEL superan a sus pasivos a corto plazo ($17.1M).

Pasivo a largo plazo: Los activos a corto plazo de RCEL ($63.9M) superan a sus pasivos a largo plazo ($51.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: RCEL tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de RCEL ha crecido de 0% a 348% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: RCEL tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: Datos insuficientes para determinar si RCEL tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.


Descubre empresas con salud financiera